PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of annrheumdAnnals of the Rheumatic DiseasesVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
 
Ann Rheum Dis. 1980 August; 39(4): 377–380.
PMCID: PMC1000560

Methylprednisolone pulse therapy for nonrenal lupus erythematosus.

Abstract

High-dose intravenous methylprednisolone therapy has previously been shown to be efficacious in the treatment of renal lupus erythematosus. The present report presents 2 patients with life-threatening, nonrenal lupus erythematosus. One patient had coma and seizures, while the other had sever thrombocytopenia and anaemia. Both had failed to respond to oral corticosteroid therapy in high doses but had dramatic clinical responses with intravenous methylprednisolone given in 'pulses.' Possible mechanisms of clinical improvement are discussed.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (679K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Bell PR, Briggs JD, Calman KC, Paton AM, Wood RF, Macpherson SG, Kyle K. Reversal of acute clinical and experimental organ rejection using large doses of intravenous prednisolone. Lancet. 1971 May 1;1(7705):876–880. [PubMed]
  • Feduska NJ, Turcotte JG, Gikas PW, Bacon GE, Penner JA. Reversal of renal allograft rejection with intravenous methylprednisolone "pulse" therapy. J Surg Res. 1972 Mar;12(3):208–215. [PubMed]
  • Cole BR, Brocklebank JT, Kienstra RA, Kissane JM, Robson AM. "Pulse" methylprednisolone therapy in the treatment of severe glomerulonephritis. J Pediatr. 1976 Feb;88(2):307–314. [PubMed]
  • Cathcart ES, Idelson BA, Scheinberg MA, Couser WG. Beneficial effects of methylprednisolone "pulse" therapy in diffuse proliferative lupus nephritis. Lancet. 1976 Jan 24;1(7952):163–166. [PubMed]
  • Nebout T, Sobel A, Lagrue G. Intravenous methylprednisolone pulses in diffuse proliferative lupus nephritis. Lancet. 1977 Apr 23;1(8017):909–909. [PubMed]
  • Ponticelli C, Tarantino A, Pioltelli P, Invernizzi F. High-dose methylprednisolone pulses in active lupus nephritis. Lancet. 1977 May 14;1(8020):1063–1063. [PubMed]
  • Fauci AS, Dale DC, Balow JE. Glucocorticosteroid therapy: mechanisms of action and clinical considerations. Ann Intern Med. 1976 Mar;84(3):304–315. [PubMed]
  • BOGGS DR, ATHENS JW, CARTWRIGHT GE, WINTROBE MM. THE EFFECT OF ADRENAL GLUCOCORTICOSTEROIDS UPON THE CELLULAR COMPOSITION OF INFLAMMATORY EXUDATES. Am J Pathol. 1964 May;44:763–773. [PubMed]
  • WEISSMANN G, THOMAS L. Studies on lysosomes. I. The effects of endotoxin, endotoxin tolerance, and cortisone on the release of acid hydrolases from a granular fraction of rabbit liver. J Exp Med. 1962 Oct 1;116:433–450. [PMC free article] [PubMed]
  • David DS, Grieco MH, Cushman P., Jr Adrenal glucocorticoids after twenty years. A review of their clinically relevant consequences. J Chronic Dis. 1970 Mar;22(10):637–711. [PubMed]
  • Butler WT, Rossen RD. Effects of corticosteroids on immunity in man. I. Decreased serum IgG concentration caused by 3 or 5 days of high doses of methylprednisolone. J Clin Invest. 1973 Oct;52(10):2629–2640. [PMC free article] [PubMed]
  • Levinsky RJ, Cameron JS, Soothill JF. Serum immune complexes and disease activity in lupus nephritis. Lancet. 1977 Mar 12;1(8011):564–567. [PubMed]
  • Fan PT, Yu DT, Clements PJ, Fowlston S, Eisman J, Bluestone R. Effect of corticosteroids on the human immune response: comparison of one and three daily 1 gm intravenous pulses of methylprednisolone. J Lab Clin Med. 1978 Apr;91(4):625–634. [PubMed]
  • Yu DT, Clements PJ, Paulus HE, Peter JB, Levy J, Barnett EV. Human lymphocyte subpopulations. Effect of corticosteroids. J Clin Invest. 1974 Feb;53(2):565–571. [PMC free article] [PubMed]
  • Claman HN. Corticosteroids and lymphoid cells. N Engl J Med. 1972 Aug 24;287(8):388–397. [PubMed]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Group